Sponsors

On the cusp of change – the future of clinical viscosity testing

In the second of two articles for Pathology in Practice, retired biomedical scientist David Norcliffe, with David Manuel, looks at how clinical viscosity testing can be used more widely, with the measurement of viscosity having a considerable number of possible applications which are receiving further investigation.

Since the measurement of plasma viscosity (PV) in 1971,1 PV testing has become available in many haematology laboratories and has become a relatively well understood, fast, reliable, and standardised test. That said, the measurement and clinical application of PV is an ongoing progressive process, such as in the study by Gleghorn et al.2

Viscosity testing appears to be on the cusp of change. As its application during the pandemic has been realised, clinicians are starting to question where else this simple test may be used and how it may contribute to other conditions, to patient outcomes, and to efficiency savings.

At a time when resources are challenged, taking time to think creatively about what we do and how can be challenging. We are often too overwhelmed by the day job. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024